Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability

NCT02270736 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Troublesome Sialorrhea
Cerebral Palsy
Stroke
Traumatic Brain Injury
Intellectual Disability

Interventions

DRUG: NT 201 Placebo
DRUG: NT 201

Sponsor

Merz Pharmaceuticals GmbH